Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


Articles published in Cancer Res

Retrieve available abstracts of 26 articles:
HTML format
Text format



Single Articles


    June 2017
  1. AKIEL M, Guo C, Li X, Rajasekaran D, et al
    IGFBP7 Deletion Promotes Hepatocellular Carcinoma.
    Cancer Res. 2017 Jun 15. pii: canres.2885.2016.
    PubMed     Text format     Abstract available


    April 2017
  2. JARIWALA N, Rajasekaran D, Mendoza RG, Shen XN, et al
    Oncogenic Role of SND1 in Development and Progression of Hepatocellular Carcinoma.
    Cancer Res. 2017 Apr 20. pii: canres.0298.2017.
    PubMed     Text format     Abstract available


  3. YUE F, Li W, Zou J, Jiang X, et al
    Spermidine prolongs lifespan and prevents liver fibrosis and hepatocellular carcinoma by activating MAP1S-mediated autophagy.
    Cancer Res. 2017 Apr 6. pii: canres.3462.2016.
    PubMed     Text format     Abstract available


    March 2017
  4. QIAO G, Qin J, Kunda N, Calata J, et al
    LIGHT elevation enhances immune eradication of colon cancer metastases.
    Cancer Res. 2017 Mar 1. pii: canres.1655.2016.
    PubMed     Text format     Abstract available


    February 2017
  5. LIN DC, Mayakonda A, Dinh HQ, Huang P, et al
    Genomic and epigenomic heterogeneity of hepatocellular carcinoma.
    Cancer Res. 2017 Feb 20. pii: canres.2822.2016.
    PubMed     Text format     Abstract available


  6. YAN C, Yang Q, Gong Z
    Tumor-associated neutrophils and macrophages promote gender disparity in hepatocellular carcinoma in zebrafish.
    Cancer Res. 2017 Feb 15. pii: canres.2200.2016.
    PubMed     Text format     Abstract available


    January 2017
  7. LUO C, Cheng Y, Liu Y, Chen L, et al
    SRSF2 regulates alternative splicing to drive hepatocellular carcinoma development.
    Cancer Res. 2017 Jan 12. pii: canres.1919.2016.
    PubMed     Text format     Abstract available


    December 2016
  8. MALAKAR P, Shilo A, Mogilavsky A, Stein I, et al
    Long noncoding RNA MALAT1 promotes hepatocellular carcinoma development by SRSF1 up-regulation and mTOR activation.
    Cancer Res. 2016 Dec 19. pii: canres.1508.2016.
    PubMed     Text format     Abstract available


    November 2016
  9. CHEN G, Nakamura I, Dhanasekaran R, Iguchi E, et al
    Transcriptional induction of Periostin by a Sulfatase 2-TGFbeta1-SMAD signaling axis mediates tumor angiogenesis in hepatocellular carcinoma.
    Cancer Res. 2016 Nov 21. pii: canres.2556.2015.
    PubMed     Text format     Abstract available


    October 2016
  10. MAO X, Wong SY, Tse EY, Ko FC, et al
    Mechanisms through which hypoxia-induced caveolin-1 drives tumorigenesis and metastasis in hepatocellular carcinoma.
    Cancer Res. 2016 Oct 26. pii: canres.1031.2016.
    PubMed     Text format     Abstract available


    September 2016
  11. TANG B, Qi G, Tang F, Yuan S, et al
    Aberrant JMJD3 expression upregulates Slug to promote migration, invasion and stem cell-like behaviors in hepatocellular carcinoma.
    Cancer Res. 2016 Sep 20. pii: canres.3029.2015.
    PubMed     Text format     Abstract available


  12. ALLAIN C, Angenard G, Clement B, Coulouarn C, et al
    Integrative genomic analysis identifies the core transcriptional hallmarks of human hepatocellular carcinoma.
    Cancer Res. 2016 Sep 12. pii: canres.1559.2016.
    PubMed     Text format     Abstract available


  13. ZHANG L, Ge C, Zhao F, Zhang Y, et al
    NRBP2 overexpression increases the chemosensitivity of hepatocellular carcinoma cells via Akt signaling.
    Cancer Res. 2016 Sep 7. pii: canres.0937.2016.
    PubMed     Text format     Abstract available


    August 2016
  14. WOLF B, Krieg K, Falk C, Breuhahn K, et al
    Inducing differentiation of premalignant hepatic cells as a novel therapeutic strategy in hepatocarcinoma.
    Cancer Res. 2016 Aug 3. pii: canres.3453.2015.
    PubMed     Text format     Abstract available


    June 2016
  15. LI K, Shen B, Cheng X, Ma D, et al
    Phenotypic and signaling consequences of a novel aberrantly spliced transcript FGF receptor-3 in hepatocellular carcinoma.
    Cancer Res. 2016 Jun 7. pii: canres.3385.2015.
    PubMed     Text format     Abstract available


    May 2016
  16. RIZZA S, Montagna C, Cardaci S, Maiani E, et al
    <i>S</i>-nitrosylation of the mitochondrial chaperone TRAP1 sensitizes hepatocellular carcinoma cells to inhibitors of succinate dehydrogenase.
    Cancer Res. 2016 May 23. pii: canres.2637.2015.
    PubMed     Text format     Abstract available


    April 2016
  17. HIRATA H, Sugimachi K, Komatsu H, Ueda M, et al
    Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
    Cancer Res. 2016 Apr 6. pii: canres.2601.2015.
    PubMed     Text format     Abstract available


    March 2016
  18. LIN D, Lei L, Liu Y, Zhang Y, et al
    Membrane IL1alpha Inhibits the Development of Hepatocellular Carcinoma via Promoting T- and NK-cell Activation.
    Cancer Res. 2016.
    PubMed     Text format     Abstract available


  19. LU Y, Li N, Gao L, Xu YJ, et al
    Acetylcarnitine is a candidate diagnostic and prognostic biomarker of hepatocellular carcinoma.
    Cancer Res. 2016 Mar 14. pii: canres.3199.2015.
    PubMed     Text format     Abstract available


  20. LIU L, Zhao X, Zhao L, Li J, et al
    Arginine Methylation of SREBP1a via PRMT5 Promotes De Novo Lipogenesis and Tumor Growth.
    Cancer Res. 2016;76:1260-72.
    PubMed     Text format     Abstract available


    February 2016
  21. MARKOWITZ GJ, Yang P, Fu J, Michelotti GA, et al
    Inflammation-dependent IL-18 signaling restricts hepatocellular carcinoma growth by enhancing the accumulation and activity of tumor-infiltrating lymphocytes.
    Cancer Res. 2016 Feb 18. pii: canres.1548.2015.
    PubMed     Text format     Abstract available


  22. YE LY, Chen W, Bai XL, Xu XY, et al
    Hypoxia-Induced Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma Induces an Immunosuppressive Tumor Microenvironment to Promote Metastasis.
    Cancer Res. 2016.
    PubMed     Text format     Abstract available


    January 2016
  23. BORGHESAN M, Fusilli C, Rappa F, Panebianco C, et al
    DNA Hypomethylation and Histone Variant macroH2A1 Synergistically Attenuate Chemotherapy-Induced Senescence to Promote Hepatocellular Carcinoma Progression.
    Cancer Res. 2016.
    PubMed     Text format     Abstract available


  24. TANEI T, Leonard F, Liu X, Alexander JF, et al
    Redirecting Transport of Nanoparticle Albumin-Bound Paclitaxel to Macrophages Enhances Therapeutic Efficacy against Liver Metastases.
    Cancer Res. 2016;76:429-39.
    PubMed     Text format     Abstract available


    December 2015
  25. CHEN HN, Yuan K, Xie N, Wang K, et al
    PDLIM1 stabilizes the E-cadherin/beta-catenin complex to prevent epithelial-mesenchymal transition and metastatic potential of colorectal cancer cells.
    Cancer Res. 2015 Dec 23. pii: canres.1962.2015.
    PubMed     Text format     Abstract available


    April 2015
  26. BONASTRE E, Verdura S, Zondervan I, Facchinetti F, et al
    PARD3 Inactivation in Lung Squamous Cell Carcinomas Impairs STAT3 and Promotes Malignant Invasion.
    Cancer Res. 2015;75:1287-97.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: